B Cell Activation and Plasma Cell Differentiation Are Promoted by IFN-λ in Systemic Lupus Erythematosus.
B Cell Activation and Plasma Cell Differentiation Are Promoted by IFN-λ in Systemic Lupus Erythematosus.
复制标题
DOI:
10.4049/jimmunol.2100339
复制
发表时间:
2021-12-01
期刊:
影响因子:
--
通讯作者:
Anolik JH
中科院分区:
文献类型:
--
作者:
Barnas JL;Albrecht J;Meednu N;Alzamareh DF;Baker C;McDavid A;Looney RJ;Anolik JH
Type I interferon (IFN) is essential for viral clearance but also contributes to the pathogenesis of autoimmune diseases, such as systemic lupus erythematosus (SLE), via aberrant nucleic acid sensing pathways leading to autoantibody production. Type III IFN (IFN-λ) is now appreciated to have a non-redundant role in viral infection, but few studies have addressed the effects of IFN-λ on immune cells given the more restricted expression of its receptor primarily to the epithelium. Here, we demonstrate that B cells display a prominent IFN gene expression profile in lupus patients. Serum levels of IFN-λ are elevated in SLE and positively correlate with B cell subsets associated with autoimmune plasma cell (PC) development, including CD11c+ T-bet+ CD21- B cells. Although B cell subsets express all IFN receptors, IFNLR1 strongly correlates with the CD11c+ CD21- B cell expansion, suggesting that IFN-λ may be an unappreciated driver of the SLE IFN signature and B cell abnormalities. We show that IFN-λ potentiates gene transcription in human B cells typically attributed to type I IFN as well as expansion of T-bet expressing B cells after BCR and TLR7/8 stimulation. Further, IFN-λ promotes TLR7/8-mediated plasmablast differentiation and increased IgM production. CD11c+ B cells demonstrate IFN-λ hyper-responsive signaling compared to other B cell subsets suggesting that IFN-λ accelerates PC differentiation through this putative extra-follicular pathway. In summary, our data support type III IFN-λ as a cytokine promoting the antibody-secreting cell pool in human viral and autoimmune disease.
登录
查看更多内容
影响因子:
4.9
作者:
Grammer AC;Lipsky PE
通讯作者:
Lipsky PE
影响因子:
7.3
作者:
Hemann EA;Gale M Jr;Savan R
通讯作者:
Savan R
DOI:
10.1016/s2213-2600(20)30566-x
发表时间:
2021-05
期刊:
The Lancet. Respiratory medicine
影响因子:
--
作者:
Feld JJ;Kandel C;Biondi MJ;Kozak RA;Zahoor MA;Lemieux C;Borgia SM;Boggild AK;Powis J;McCready J;Tan DHS;Chan T;Coburn B;Kumar D;Humar A;Chan A;O'Neil B;Noureldin S;Booth J;Hong R;Smookler D;Aleyadeh W;Patel A;Barber B;Casey J;Hiebert R;Mistry H;Choong I;Hislop C;Santer DM;Lorne Tyrrell D;Glenn JS;Gehring AJ;Janssen HLA;Hansen BE
通讯作者:
Hansen BE
影响因子:
20.3
作者:
Hao, Yi;O'Neill, Patrick;Cancro, Michael P.
通讯作者:
Cancro, Michael P.
影响因子:
4.9
作者:
Hjorton, Karin;Hagberg, Niklas;Ronnblom, Lars
通讯作者:
Ronnblom, Lars